Home›People›Diamantis Xylas
Diamantis Xylas

Diamantis Xylas

Catalio Capital and director at Spiral Therapeutics.

Director
Updated Nov 10, 2026·Latest SEC filing Apr 16, 2026·Suggest an edit

About Diamantis Xylas

Diamantis Xylas is a catalio capital and director at Spiral Therapeutics.

Diamantis Xylas first appears on SEC filings in 2022.

Experience

This experience comes from SEC filings. The years are when the filings name Diamantis Xylas in the role, so the role may have started earlier or lasted longer.

Spiral Therapeutics Inc
Catalio Capital and director
2022 – 2026 · South San Francisco, CA
Develops drug treatments for people with inner ear disorders.

Key Colleagues at Startups

The people Diamantis Xylas works with at each company, as listed on that company's latest Form D.

Spiral Therapeutics Inc · Form D, Apr 16, 2026
WT
Eugene De Juan
Eugene De Juan
Executive Chairman
Anthony Adamis
Anthony Adamis
Independent and director
Jean-Frederic Paulsen
Jean-Frederic Paulsen
Ferring Ventures SA and director
Hugo Peris
Hugo Peris
Founder & CEO, director
Angela Macfarlane
Angela Macfarlane
Independent and director

Sources

  1. SECSpiral Therapeutics Inc Form D, filed Apr 16, 2026